Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 02 Mar 2026 for Thermo Fisher Scientific INC., €369k. Read the official filing
Filing timeline
BuySaleMichel Lagarde
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michel Lagarde: trading record in brief
This profile gathers the share dealings of Michel Lagarde across 2 companies, led by Thermo Fisher Scientific Inc. and Vertex Pharmaceuticals INC / MA. Over a trading history stretching from 7 May 2021 to 28 February 2026, the count stands at 32 filings.
Sales make up the whole of the open-market record (1 sale, €2.5M). Other entries cover 24 share grants and 7 option exercises.
The newest entry dates from 2 March 2026: a share grant of €369k, in Thermo Fisher Scientific Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michel Lagarde
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
836.88 shares@ US$521.111.6% of flowCommon StockSEC:0000097745-26-000047:0
2,231 shares0Common StockSEC:0000097745-26-000036:0
18,637 shares@ US$105.177.2% of flowCommon StockSEC:0000097745-25-000180:0
36,000 shares@ US$105.1714.0% of flowCommon StockSEC:0000097745-25-000178:0
4,638 shares@ US$253.995.6% of flowCommon StockSEC:0000097745-25-000166:0
262.058 shares@ US$489.740.6% of flowCommon StockSEC:0000097745-25-000125:0
432.976 shares@ US$528.961.0% of flowCommon StockSEC:0001127602-25-007924:0
2,231 shares0Common StockSEC:0001127602-25-006243:0
262.058 shares@ US$613.140.6% of flowCommon StockSEC:0001127602-24-023151:0
504.29 shares@ US$606.121.2% of flowCommon StockSEC:0001127602-24-022979:0
20,000 shares@ US$105.178.7% of flowCommon StockSEC:0001127602-24-015444:0
1,012.828 shares@ US$572.032.4% of flowCommon StockSEC:0001127602-24-007593:0
511.502 shares@ US$564.711.2% of flowCommon StockSEC:0001127602-24-006826:0
2,275 shares0Common StockSEC:0001127602-24-006601:0
1,132 shares0Common StockSEC:0001209191-23-052535:0
642.089 shares@ US$541.591.4% of flowCommon StockSEC:0001127602-23-023353:0
504.292 shares@ US$545.241.1% of flowCommon StockSEC:0001127602-23-023239:0
131 shares@ US$559.440.3% of flowCommon StockSEC:0001127602-23-009276:0
1,019 shares@ US$541.762.3% of flowCommon StockSEC:0001127602-23-008372:0
1,809 shares0Common StockSEC:0001127602-23-007099:0
589 shares@ US$585.471.5% of flowCommon StockSEC:0001127602-22-021709:0
385 shares@ US$572.971.0% of flowCommon StockSEC:0001127602-22-021551:0
6,049 shares@ US$210.680.0007% mcap6.9% of flowCommon StockSEC:0001127602-22-016032:0
14,900 shares@ US$190.590.0016% mcap15.3% of flowCommon StockSEC:0001127602-22-015697:0
120 shares@ US$547.320.0000% mcap0.3% of flowCommon StockSEC:0001127602-22-008623:0
25 of 32 declarations
